Analyst Reco. MorphoSys AG OTC Markets

Equities

Delayed OTC Markets Other stock markets 09:30:02 2024-06-21 EDT			5-day change	1st Jan Change
72.38 ^USD	+1.40%		+1.40%	+76.54%

06-24	INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax	DP
06-24	MorphoSys AG(XTRA:MOR) dropped from Germany MDAX Index (Performance)	CI

MORPHOSYS : UBS reiterates its Neutral rating	05-06	ZD
MORPHOSYS : UBS remains Neutral	04-30	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	04-11	DJ
MORPHOSYS : UBS sticks Neutral	02-16	ZD
MORPHOSYS : UBS revises his opinion and turns to Neutral	02-07	ZD
MORPHOSYS : UBS remains its Buy rating	02-07	ZD
MORPHOSYS : UBS reiterates its Buy rating	02-06	ZD
MORPHOSYS : JP Morgan reaffirms its Buy rating	02-05	ZD
MORPHOSYS : UBS reiterates its Buy rating	02-05	ZD
MORPHOSYS : Deutsche Bank sticks Neutral	01-31	ZD
MORPHOSYS : JP Morgan gives a Buy rating	01-30	ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros	01-30	DP
MORPHOSYS : UBS remains its Buy rating	01-30	ZD
MORPHOSYS : UBS reiterates its Buy rating	01-29	ZD
MORPHOSYS : JP Morgan reiterates its Buy rating	01-15	ZD
MORPHOSYS : Receives a Buy rating from JP Morgan	01-02	ZD
MORPHOSYS : Gets a Neutral rating from Goldman Sachs	12-19	ZD
Wells Fargo Adjusts MorphoSys' Price Target to $17 From $10, Keeps Overweight Rating	12-15	MT
MORPHOSYS : Deutsche Bank reiterates its Neutral rating	12-15	ZD
MORPHOSYS : JP Morgan gives a Buy rating	12-14	ZD

No results for this search